These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26501981)

  • 1. Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods.
    Park JH; Sevin M; Ramla S; Truffot A; Verrier T; Bouchot D; Courtois M; Bas M; Benali S; Bailly F; Favre B; Guy J; Martin L; Maynadié M; Carillo S; Girodon F
    PLoS One; 2015; 10(10):e0141010. PubMed ID: 26501981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of CALR mutation testing for clinical diagnosis.
    Maier CL; Fisher KE; Jones HH; Hill CE; Mann KP; Zhang L
    Am J Clin Pathol; 2015 Nov; 144(5):738-45. PubMed ID: 26486738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.
    Guo H; Chen X; Tian R; Chang J; Li J; Tan Y; Xu Z; Ren F; Zhao J; Pan J; Zhang N; Wang X; He J; Yang W; Wang H
    PLoS One; 2015; 10(9):e0138250. PubMed ID: 26375990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring.
    Chi J; Manoloukos M; Pierides C; Nicolaidou V; Nicolaou K; Kleopa M; Vassiliou G; Costeas P
    Ann Hematol; 2015 Mar; 94(3):399-408. PubMed ID: 25349114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening PCR Versus Sanger Sequencing: Detection of CALR Mutations in Patients With Thrombocytosis.
    Jeong JH; Lee HT; Seo JY; Seo YH; Kim KH; Kim MJ; Lee JH; Park J; Hong JS; Park PW; Ahn JY
    Ann Lab Med; 2016 Jul; 36(4):291-9. PubMed ID: 27139600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CALR mutation profile in Irish patients with myeloproliferative neoplasms.
    Haslam K; Conneally E; Flynn CM; Cahill MR; Gilligan O; O'Shea D; Langabeer SE
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):112-5. PubMed ID: 27352261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical validation of a multipurpose assay for detection and genotyping of CALR mutations in myeloproliferative neoplasms.
    Mehrotra M; Luthra R; Singh RR; Barkoh BA; Galbincea J; Mehta P; Goswami RS; Jabbar KJ; Loghavi S; Medeiros LJ; Verstovsek S; Patel KP
    Am J Clin Pathol; 2015 Nov; 144(5):746-55. PubMed ID: 26486739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations of calreticulin in myeloproliferative neoplasms.
    Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
    N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calreticulin mutation analysis in non-mutated Janus kinase 2 essential thrombocythemia patients in Chiang Mai University: analysis of three methods and clinical correlations.
    Rattarittamrong E; Tantiworawit A; Kumpunya N; Wongtagan O; Tongphung R; Phusua A; Chai-Adisaksopha C; Hantrakool S; Rattanathammethee T; Norasetthada L; Charoenkwan P; Lekawanvijit S
    Hematology; 2018 Oct; 23(9):613-619. PubMed ID: 29521158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant specific anti calreticulin antibody (CAL2) immunohistochemistry as a screening test for calreticulin (CALR) mutation testing.
    Rahman K; Chandra D; Singh MK; Gupta R; Sharma A; Paul P; Kumar S; Sharma S; Nityanand S
    Int J Lab Hematol; 2020 Oct; 42(5):604-611. PubMed ID: 32463176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms.
    Andrici J; Farzin M; Clarkson A; Sioson L; Sheen A; Watson N; Toon CW; Koleth M; Stevenson W; Gill AJ
    Pathology; 2016 Jun; 48(4):319-24. PubMed ID: 27114372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High resolution melting analysis for detecting of JAK2V617F mutation in patients with myeloproliferative neoplasms].
    Chen HH; Yang JL; Lu HF; Zhou WJ; Yao F; Deng L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):112-6. PubMed ID: 24598662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of
    Giannopoulos A; Rougkala N; Loupis T; Mantzourani M; Viniou NA; Variami E; Vassilakopoulos TP; Dryllis G; Kotsianidis I; Gougopoulou T; Politou M; Konstantopoulos K; Vassilopoulos G
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019009. PubMed ID: 30671215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms.
    Jones AV; Ward D; Lyon M; Leung W; Callaway A; Chase A; Dent CL; White HE; Drexler HG; Nangalia J; Mattocks C; Cross NC
    Leuk Res; 2015 Jan; 39(1):82-7. PubMed ID: 25499808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrosequencing-based quantitative measurement of CALR mutation allele burdens and their clinical implications in patients with myeloproliferative neoplasms.
    Oh Y; Song IC; Kim J; Kwon GC; Koo SH; Kim SY
    Clin Chim Acta; 2018 Aug; 483():183-191. PubMed ID: 29727699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
    Gangat N; Wassie EA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Passamonti F; Tefferi A
    Eur J Haematol; 2015 Jan; 94(1):31-6. PubMed ID: 24889737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel molecular assay using hybridisation probes and melt curve analysis for
    Keaney T; O'Connor L; Krawczyk J; Abdelrahman MA; Hayat AH; Murray M; O'Dwyer M; Percy M; Langabeer S; Haslam K; Glynn B; Mullen C; Keady E; Lahiff S; Smith TJ
    J Clin Pathol; 2017 Aug; 70(8):662-668. PubMed ID: 28143941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutant calreticulin and the molecular mechanisms in development of myeloproliferative neoplasms].
    Araki M
    Rinsho Ketsueki; 2020; 61(8):937-944. PubMed ID: 32908058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of CALR type 1 and type 2 mutations using PNA-LNA clamping loop-mediated isothermal amplification on a CD-like microfluidic chip.
    Cao G; Kong J; Xing Z; Tang Y; Zhang X; Xu X; Kang Z; Fang X; Guan M
    Anal Chim Acta; 2018 Sep; 1024():123-135. PubMed ID: 29776538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.